{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T10:09:22Z","timestamp":1781258962127,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201550"],"award-info":[{"award-number":["82201550"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research Seed Fund of Peking University First Hospital","award":["2018SF033"],"award-info":[{"award-number":["2018SF033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The coexistence of two myositis-specific autoantibodies (MSA) is considered extremely rare. We describe three patients with both anti-signal recognition particle (SRP) antibodies and another MSA in serum.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a retrospective clinical data collection and follow-up studies of the clinical manifestations and treatment outcome of three patients positive with anti-SRP antibodies and other MSAs. IgG antibodies against MSAs were detected using commercial line immunoblot assay.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The tests of MSA showed positive result of anti-SRP antibodies and another one MSA including anti-TIF1-\u03b3, anti-Jo1, or anti-EJ antibodies, respectively. The proximal muscle weakness appeared in 2 patients; interstitial lung disease presented in 2 patients. The serum CK level was elevated in 1 patient. The muscle biopsy showed necrotizing myopathy in 1 patient and deposition of membrane attack complex on scattered myofibers in the other one patient. One of the two patients with interstitial lung disease died because of respiratory failure. One patient had completely improved and the other one showed partial remission after immunosuppressive therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The patients with anti-SRP antibodies co-occurred with the other MSA may have various clinical characteristics. The clinicopathological phenotypes of these patients seem to be mainly caused by one of the MSAs, namely the responsible antibody.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-01363-5","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T15:01:57Z","timestamp":1697122917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["What should we expect when two myositis-specific antibodies coexist in a patient"],"prefix":"10.1186","volume":"28","author":[{"given":"Yiming","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"1363_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","volume":"14","author":"NJ McHugh","year":"2018","unstructured":"McHugh NJ, Tansley SL. Autoantibodies in myositis. Nat Rev Rheumatol. 2018;14:290\u2013302.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1363_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13023-015-0277-y","volume":"10","author":"S Suzuki","year":"2015","unstructured":"Suzuki S, Nishikawa A, Kuwana M, Nishimura H, Watanabe Y, Nakahara J, Hayashi YK, Suzuki N, Nishino I. Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients[J]. Orphanet J Rare Dis. 2015;10(1):61.","journal-title":"Orphanet J Rare Dis"},{"key":"1363_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/acr.22920","volume":"69","author":"I Pinal-Fernandez","year":"2016","unstructured":"Pinal-Fernandez I, Parks C, Werner JL, et al. Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle[J]. Arthritis Care Res. 2016;69:263\u201370.","journal-title":"Arthritis Care Res"},{"key":"1363_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/joim.12451","volume":"280","author":"Z Betteridge","year":"2016","unstructured":"Betteridge Z, McHugh N. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med. 2016;280:8\u201323.","journal-title":"J Intern Med"},{"issue":"7","key":"1363_CR5","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10067-010-1394-6","volume":"29","author":"M Vincze","year":"2010","unstructured":"Vincze M, Moln\u00e1r PA, Tumpek J, et al. An unusual association: anti-Jo1 and anti-SRP antibodies in the serum of a patient with polymyositis[J]. Clin Rheumatol. 2010;29(7):811\u20134.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"1363_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jocn.2014.04.031","volume":"22","author":"A Malkan","year":"2015","unstructured":"Malkan A, Cappelen-Smith C, Beran R, et al. Anti-synthetase syndrome associated with anti PL-12 and anti-Signal recognition particle antibodies and a necrotizing auto-immune myositis[J]. J Clin Neurosci. 2015;22(2):396\u20138.","journal-title":"J Clin Neurosci"},{"issue":"7","key":"1363_CR7","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2169\/internalmedicine.51.6566","volume":"51","author":"K Sugie","year":"2012","unstructured":"Sugie K, Tonomura Y, Ueno S. Characterization of dermatomyositis with coexistence of Anti-Jo-1 and Anti-SRP Antibodies[J]. Intern Med. 2012;51(7):799\u2013802.","journal-title":"Intern Med"},{"key":"1363_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/art.11484","volume":"50","author":"A Kao","year":"2004","unstructured":"Kao A. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy[J]. Arthditis Rheum. 2004;50:209\u201315.","journal-title":"Arthditis Rheum"},{"key":"1363_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jns.2018.02.040","volume":"388","author":"K Tadokoro","year":"2018","unstructured":"Tadokoro K, Ohta Y, Sasaki R, et al. A mild myopathy with anti-SRP plus anti-PL-12 antibodies successfully treated by oral steroid monotherapy[J]. J Neurol Sci. 2018;388:7\u20139.","journal-title":"J Neurol Sci"},{"key":"1363_CR10","first-page":"bcr2017","volume":"2017","author":"RO Akintayo","year":"2017","unstructured":"Akintayo RO, Agbola OF, Adeyemo AW, et al. Hyperacute muscle weakness in an unusual coexistence of antisignal recognition particle and anti-Mi-2 antibodies[J]. BMJ Case Reports. 2017;2017:bcr2017-219221.","journal-title":"BMJ Case Reports"},{"issue":"4","key":"1363_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.pathol.2016.03.012","volume":"48","author":"C Bundell","year":"2016","unstructured":"Bundell C, Rojana-Udomsart A, Mastaglia F, et al. Diagnostic performance of a commercial immunoblot assay for myositis antibody testing[J]. Pathology. 2016;48(4):363\u20136.","journal-title":"Pathology"},{"key":"1363_CR12","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1007\/s00415-019-09266-4","volume":"266","author":"F Montagnese","year":"2019","unstructured":"Montagnese F, Baba\u010di\u0107 H, Eichhorn P, et al. Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective study. J Neurol. 2019;266:1358\u201366.","journal-title":"J Neurol"},{"issue":"9","key":"1363_CR13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","volume":"13","author":"JC Lega","year":"2014","unstructured":"Lega JC, Fabien N, Reynaud Q, et al. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome[J]. Autoimmun Rev. 2014;13(9):883\u201391.","journal-title":"Autoimmun Rev"},{"key":"1363_CR14","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1001\/jamaneurol.2017.0934","volume":"74","author":"E Noguchi","year":"2017","unstructured":"Noguchi E, Uruha A, Suzuki S, et al. Skeletal Muscle Involvement in Antisynthetase Syndrome. JAMA Neurol. 2017;74:992\u20139.","journal-title":"JAMA Neurol"},{"key":"1363_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaut.2017.06.007","volume":"84","author":"SL Tansley","year":"2017","unstructured":"Tansley SL, et al. Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort. J Autoimmun. 2017;84:55\u201364.","journal-title":"J Autoimmun"},{"key":"1363_CR16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/art.33403","volume":"64","author":"M Fujimoto","year":"2012","unstructured":"Fujimoto M, et al. Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum. 2012;64:513\u201322.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1363_CR17","first-page":"598","volume":"35","author":"A Flechsig","year":"2017","unstructured":"Flechsig A, Rose T, Barkhudarova F, et al. What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3. Clin Exp Rheumatol. 2017;35(4):598\u2013606.","journal-title":"Clin Exp Rheumatol"},{"key":"1363_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13559","author":"L Nu\u00f1o-Nu\u00f1o","year":"2019","unstructured":"Nu\u00f1o-Nu\u00f1o L, Joven BE, Carreira PE, et al. Overlap myositis, a distinct entity beyond primary inflammatory myositis: a retrospective analysis of a large cohort from the REMICAM registry. Int J Rheum Dis. 2019. https:\/\/doi.org\/10.1111\/1756-185X.13559.","journal-title":"Int J Rheum Dis"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01363-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01363-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01363-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T20:27:11Z","timestamp":1700598431000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01363-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1363"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01363-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]},"assertion":[{"value":"16 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants or their legal surrogate. Research Ethics Committee of The First Hospital of Peking University approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the participants or their legal surrogate gave written consent for their personal or clinical details along with any identifying images to be published in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"429"}}